Search research articles
Contact Us
Filters
Showing results (81-90 of 129) with videos related to
Page
of 13
Sort By:
Scientific Reports
|
May 19, 2026
Human cathelicidin peptide LL-37 compacts nucleic acids and alters neutrophil extracellular trap structure
Claudia Zielke, Behzad Rad, Josefine E Nielsen, et al.
Antiviral Research
|
January 25, 2024
Antiviral effect of peptoids on hepatitis B virus infection in cell culture
Asako Murayama, Hitomi Igarashi, Norie Yamada, et al.
Journal of Applied Microbiology
|
February 11, 2025
Antimicrobial activity of peptoids against Metallo-β-lactamase-producing Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and other WHO priority pathogens, including Candida auris
Shyam Kumar Mishra, Muhammad Yasir, Rajesh Kuppusamy, et al.
Frontiers in Immunology
|
May 31, 2022
Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis
Karim M Aloul, Josefine Eilsø Nielsen, Erwin B Defensor, et al.
ACS Infectious Diseases
|
August 26, 2022
Anti-persister and Anti-biofilm Activity of Self-Assembled Antimicrobial Peptoid Ellipsoidal Micelles
Jennifer S Lin, Laurent A Bekale, Natalia Molchanova, et al.
Journal of Clinical Epidemiology
|
October 30, 2024
Paper 1: introduction to the series
Meera Viswanathan, Nila A Sathe, Vivian Welch, et al.
Research Square
|
November 1, 2024
Mapping of catecholaminergic denervation, neurodegeneration, and inflammation in 6-OHDA-treated Parkinson's disease mice
Matteo Santoro, Rachel K Lam, Sarah E Blumenfeld, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 3, 2021
Potent Antiviral Activity against HSV-1 and SARS-CoV-2 by Antimicrobial Peptoids
Gill Diamond, Natalia Molchanova, Claudine Herlan, et al.
NPJ Parkinson'S Disease
|
February 11, 2025
Mapping of catecholaminergic denervation, neurodegeneration, and inflammation in 6-OHDA-treated Parkinson's disease mice
Matteo Santoro, Rachel K Lam, Sarah E Blumenfeld, et al.
Journal of Alzheimer'S Disease : JAD
|
July 22, 2017
Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly
Ersilia De Lorenzi, Marcella Chiari, Raffaella Colombo, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 129) with videos related to
Sort By:
Page
of 13
Scientific Reports
|
May 19, 2026
Human cathelicidin peptide LL-37 compacts nucleic acids and alters neutrophil extracellular trap structure
Claudia Zielke, Behzad Rad, Josefine E Nielsen, et al.
Antiviral Research
|
January 25, 2024
Antiviral effect of peptoids on hepatitis B virus infection in cell culture
Asako Murayama, Hitomi Igarashi, Norie Yamada, et al.
Journal of Applied Microbiology
|
February 11, 2025
Antimicrobial activity of peptoids against Metallo-β-lactamase-producing Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and other WHO priority pathogens, including Candida auris
Shyam Kumar Mishra, Muhammad Yasir, Rajesh Kuppusamy, et al.
Frontiers in Immunology
|
May 31, 2022
Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis
Karim M Aloul, Josefine Eilsø Nielsen, Erwin B Defensor, et al.
ACS Infectious Diseases
|
August 26, 2022
Anti-persister and Anti-biofilm Activity of Self-Assembled Antimicrobial Peptoid Ellipsoidal Micelles
Jennifer S Lin, Laurent A Bekale, Natalia Molchanova, et al.
Journal of Clinical Epidemiology
|
October 30, 2024
Paper 1: introduction to the series
Meera Viswanathan, Nila A Sathe, Vivian Welch, et al.
Research Square
|
November 1, 2024
Mapping of catecholaminergic denervation, neurodegeneration, and inflammation in 6-OHDA-treated Parkinson's disease mice
Matteo Santoro, Rachel K Lam, Sarah E Blumenfeld, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 3, 2021
Potent Antiviral Activity against HSV-1 and SARS-CoV-2 by Antimicrobial Peptoids
Gill Diamond, Natalia Molchanova, Claudine Herlan, et al.
NPJ Parkinson'S Disease
|
February 11, 2025
Mapping of catecholaminergic denervation, neurodegeneration, and inflammation in 6-OHDA-treated Parkinson's disease mice
Matteo Santoro, Rachel K Lam, Sarah E Blumenfeld, et al.
Journal of Alzheimer'S Disease : JAD
|
July 22, 2017
Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly
Ersilia De Lorenzi, Marcella Chiari, Raffaella Colombo, et al.
Page
of 13